### Analysis

**UnitedHealth Group's Q3 2013 Earnings Call:**
- **Financial Performance:** UnitedHealth Group reported strong financial performance, with $1.53 per share earnings on revenues of $30.6 billion. Cash flows from operations were robust at $3.4 billion, and the company achieved a 12% year-over-year revenue growth.
- **Operating Costs:** Operating costs were well controlled at 15.9% of revenue, and the company expects to continue increasing productivity and realizing cost savings.
- **Medicare Advantage:** The company expects the Medicare Advantage program to face funding pressures in 2014, impacting earnings. The company is focused on improving its star ratings and managing costs.
- **Optum Business:** Optum's technology-enabled services grew strongly, and the company expects continued growth and performance in 2014.
- **International Expansion:** The company is expanding its international business, with strong growth in Brazil and other markets.
- **2014 Outlook:** The company expects its 2014 earnings outlook to be impacted by overall Medicare Advantage funding levels and the effects of a non-deductible insurer fee on Medicare. The company expects its 2014 earnings to be in a range of $5.40 to $5.50 per share, with a midpoint of $5.45 per share.

### Conclusion

UnitedHealth Group's Q3 2013 earnings call highlighted strong financial performance and growth opportunities, particularly in the Optum business. However, the company expects headwinds in 2014 due to Medicare Advantage funding pressures and other factors. The stock is likely to face short-term pressure due to tempered guidance and uncertainties around key defense contracts. The company's focus on cost-cutting measures, strategic expansions, and ongoing diversification efforts suggests long-term potential. The stock is likely to face short-term pressure due to tempered guidance and uncertainties around key defense contracts.

**Rating:** 1